PABPC1P9

Across TCGA pan-cancer cohorts, PABPC1P9 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated PABPC1P9 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher PABPC1P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PABPC1P9 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

KIRP, PAAD, and OV are the cancer types where PABPC1P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.188	0.759	<.001	66	view →
PAAD	OS	Tertile	All	0.100	0.590	<.001	36	view →
OV	OS	Tertile	IV	0.059	0.759	.006	36	view →
UCEC	DFS	Tertile	All	0.766	0.901	.002	36	view →
MESO	OS	Tertile	II,III,IV	0.162	0.583	.017	27	view →
COAD	OS	Tertile	II,III,IV	0.598	0.857	.013	21	view →
KIRC	DFS	Tertile	III,IV	0.469	0.654	.024	18	view →
LIHC	OS	Tertile	II,III,IV	0.316	0.777	.006	18	view →
LUAD	OS	Tertile	III,IV	0.276	0.686	.022	18	view →
THCA	DFS	Tertile	III,IV	0.145	0.825	<.001	18	view →
STAD	DFS	Tertile	All	0.400	0.584	.007	17	view →
ESCA	OS	Tertile	II,III,IV	0.817	0.642	.015	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

PABPC1P9–KIRP (OS)

Open the KIRP breakdown →